Cerebral Palsy Treatments
Find Cerebral Palsy Treatments
Medications for Cerebral Palsy
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Cerebral Palsy.
Found 3 Approved Drugs for Cerebral Palsy
Baclofen
Brand Names
Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax
Baclofen
Brand Names
Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax
Form: Injection, Tablet, Kit, Granule, Suspension, Solution
Method of administration: Intrathecal, Oral
FDA approval date: July 21, 1988
Classification: gamma-Aminobutyric Acid-ergic Agonist
FLEQSUVY is indicated for the treatment of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. FLEQSUVY may also be of some value in patients with spinal cord injuries and other spinal cord diseases. Limitations of Use FLEQSUVY is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. FLEQSUVY is a gamma-aminobutyric acid (GABA-ergic) agonist indicated for the treatment of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. ( 1 ) FLEQSUVY may also be of some value in patients with spinal cord injuries and other spinal cord diseases. ( 1 ) Limitations of Use FLEQSUVY is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. ( 1 )
Glycopyrrolate
Brand Names
Bevespi, Cuvposa, Glycate, Glyrx-Pf, Prevduo
Glycopyrrolate
Brand Names
Bevespi, Cuvposa, Glycate, Glyrx-Pf, Prevduo
Form: Injection, Aerosol, Tablet, Liquid, Solution
Method of administration: Respiratory (inhalation), Oral, Intravenous, Intramuscular
FDA approval date: September 30, 1990
Classification: Cholinergic Muscarinic Antagonist
BEVESPI AEROSPHERE is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Limitations of Use: BEVESPI AEROSPHERE is not indicated for the relief of acute bronchospasm or for the treatment of asthma [see Warnings and Precautions.
Cyclobenzaprine
Brand Names
AMRIX, Fexmid, Tonmya
Cyclobenzaprine
Brand Names
AMRIX, Fexmid, Tonmya
Form: Tablet, Capsule
Method of administration: Sublingual, Oral
FDA approval date: April 04, 2006
Classification: Muscle Relaxant
AMRIX ® (cyclobenzaprine hydrochloride extended-release capsules) is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, and limitation of motion. Limitations of Use: AMRIX should be used only for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted. AMRIX has not been found effective in the treatment of spasticity associated with cerebral or spinal cord disease or in children with cerebral palsy. AMRIX is a muscle relaxant indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. ( 1 ) Limitations of Use: AMRIX should be used only for short periods (up to 2 or 3 weeks) ( 1 ) AMRIX has not been found effective in the treatment of spasticity or cerebral palsy.
Showing 1-3 of 3
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances